Sensei Biotherapeutics, Inc. (SNSE)
17.90
-2.01
(-10.10%)
USD |
NASDAQ |
May 19, 10:45
Sensei Biotherapeutics Research and Development Expense (Quarterly) : 2.536M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 12.42M |
| Oncolytics Biotech, Inc. | 4.552M |
| Vir Biotechnology, Inc. | 107.00M |
| Recursion Pharmaceuticals, Inc. | 75.20M |
| Acurx Pharmaceuticals, Inc. | 0.3415M |